Hims Stock Is Climbing—But Should You Buy In Right Now?

Writers: MD Emran Khan/ 06/23/2025

The friendly, real-talk guide for office-goers and casual investors
 Trending: “Hims stock” just shot up on Google Trends after an earnings surprise

 The Accidental Investor Next Door

Last week, my neighbor Raj—who usually spends his free time setting fantasy cricket lineups—accidentally bought Hims stock on his phone.

No joke.

He thought it was some new beard oil brand, clicked Buy on Robinhood, and forgot about it.

Two days later, he calls me like:

“Bro, I’m up 30%. What even is this company?”

Let’s be real—this happens more than we admit. One second you’re checking emails, next you’re deep into a Reddit stock thread, wondering if you’re about to become the next Warren Buffett.

Well, turns out Hims isn’t a joke. It’s one of the hottest health-tech stocks in the U.S. right now—and the big players are finally paying attention.

 Why Hims Stock Is Suddenly Everywhere

 What Even Is Hims?

Hims & Hers Health Inc. is a telehealth company that started off selling treatments for hair loss and erectile dysfunction—but now covers skincare, anxiety, sleep, weight loss, and more.

Think of it as a digital pharmacy meets modern wellness clinic.
It’s subscription-based, app-powered, and millennials love it.

 Why It’s Spiking Right Now

• Stock price jumped big-time after a blowout earnings report

• Revenue up ~45% year-over-year

•  Added thousands of new subscribers (recurring revenue = gold)

•  Even CNBC and top YouTubers are buzzing about it

In the U.S., we’ve seen this shift—people want convenient, at-home care.
No more waiting rooms. No awkward pharmacy lines. Hims fills that gap perfectly.

 But Hold On—It’s Not All Green Arrows

•  Still volatile—not a blue-chip stock

•  High marketing costs + subscription churn = potential risk

•  One viral TikTok can pump it… or crash it

Too many people treat it like a meme stock when it’s really a hybrid of tech + healthcare.
And yeah—it’s not for short-term gamblers.

Let’s skip the “do your research” fluff. Here’s what actually helps:

 1. Try the Product (Seriously)

Before buying the stock, check out the Hims website.
Browse a product. Understand the funnel.
(Hint: You might leave with some gummies for sleep.)

 2. Track It on TikTok, Not Just Bloomberg

If Hims is trending in creator circles, demand’s going up.
Finance pros might ignore it—but Gen Z doesn’t.

 3. Watch Monthly Subscription Growth, Not Just Revenue

It’s not just sales—it’s retention that makes or breaks a healthtech company.

 4. Calendar Every Earnings Date

This stock moves big on earnings calls.
Set a Google alert. Don’t react late.

 5. Don’t Get Reddit-FOMO’d

Yes, someone on r/stocks made 300% last year. Doesn’t mean you will.
Read the filings, not just the memes.

 Hims Is Hot, But Be Smarter Than the Hype

Look, Hims stock is legit interesting.
It’s modern. It’s growing. And it’s doing what many healthcare companies failed to: make people actually care about their health.

But hype fades fast if performance dips.

Invest if you believe in the business model—not just because your neighbor made a lucky 30%.

And next time Raj makes a random stock buy?
I’m asking for his password.

Learn More: Here

Writer

Md Emran Khan is a passionate news writer and digital content creator focused on delivering clear, insightful, and timely updates on finance, technology, and current events. With a knack for breaking down complex topics into engaging stories, Emran aims to keep readers informed and empowered to make smart decisions. Based in USA, he blends global trends with local perspectives to bring a fresh voice to the news landscape.